Literature DB >> 1893778

Viral DNA synthesis.

C Seeger1, J Summers, W S Mason.   

Abstract

Mesh:

Substances:

Year:  1991        PMID: 1893778     DOI: 10.1007/978-3-642-76015-0_3

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  21 in total

1.  Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication.

Authors:  William R Addison; Kathie-Anne Walters; Winnie W S Wong; John S Wilson; Danuta Madej; Lawrence D Jewell; D Lorne J Tyrrell
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

2.  Pre-steady-state kinetic studies establish entecavir 5'-triphosphate as a substrate for HIV-1 reverse transcriptase.

Authors:  Robert A Domaoal; Moira McMahon; Chloe L Thio; Christopher M Bailey; Julian Tirado-Rives; Aleksander Obikhod; Mervi Detorio; Kimberly L Rapp; Robert F Siliciano; Raymond F Schinazi; Karen S Anderson
Journal:  J Biol Chem       Date:  2007-10-25       Impact factor: 5.157

3.  Mapping of the hepatitis B virus reverse transcriptase TP and RT domains by transcomplementation for nucleotide priming and by protein-protein interaction.

Authors:  R E Lanford; Y H Kim; H Lee; L Notvall; B Beames
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

4.  Insertions within epsilon affect synthesis of minus-strand DNA before the template switch for duck hepatitis B virus.

Authors:  H Jiang; D D Loeb
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  n-Butyrate, a cell cycle blocker, inhibits early amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of duck hepatocytes.

Authors:  F Turin; C Borel; M Benchaib; A Kay; C Jamard; C Guguen-Guillouzo; C Trépo; O Hantz
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

6.  Recombinant human hepatitis B virus reverse transcriptase is active in the absence of the nucleocapsid or the viral replication origin, DR1.

Authors:  M Seifer; D N Standring
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

7.  A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion.

Authors:  Anne Marie Dougherty; Haitao Guo; Gael Westby; Yuanjie Liu; Ender Simsek; Ju-Tao Guo; Anand Mehta; Pamela Norton; Baohua Gu; Timothy Block; Andrea Cuconati
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

8.  In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus.

Authors:  T Shaw; P Amor; G Civitico; M Boyd; S Locarnini
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

9.  Pharmacodynamics of (-)-beta-2',3'-dideoxy-3'-thiacytidine in chronically virus-infected woodchucks compared to its pharmacodynamics in humans.

Authors:  S J Hurwitz; B C Tennant; B E Korba; J L Gerin; R F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

10.  Double-stranded linear duck hepatitis B virus (DHBV) stably integrates at a higher frequency than wild-type DHBV in LMH chicken hepatoma cells.

Authors:  S S Gong; A D Jensen; C J Chang; C E Rogler
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.